Tuesday, 18 Dec 2018

You are here

ACR Says the New AHCA is Insufficient for Arthritis Patients

Dr. Sharad Lakhanpal, MBBS, MD, President of the American College of Rheumatology (ACR) has issued a press release condeming the insufficiencies of the newly proposed American Health Care Act (AHCA).

The ACR has studied the AHCAA and are encouraged by no exclusions for pre-existing illness, continued limits on patient copayments, caps on out-of-pocket costs, coverage for children on a parent’s insurance until age 26, and a ban on lifetime limits.

The ACR's focus is to ensure Americans have continued access to rheumatology care that lowers long-term costs and helps patients manage pain, avoid long-term disability, remain active in the workforce, and preserve their quality of life. 

Dr. Lakhanpal believes this legislation will hurt patients and rheumatology care.  Objections include:

  • proposed tax credits based on age rather than income
  • allowances for insurers to impose a 12 month 30% premium increase when there is a lapse in coverage >63 days.
  • non-recognition of ACR’s recommendations to minimize the administrative burden on doctors and to repeal the Independent Payment Advisory Board (IPAB).

“We look forward to working with Congressional leaders and the Administration to address these concerns and will continue to provide input on proposed legislation to ensure continued access to vital rheumatology healthcare services,” says Dr. Lakhanpal.



- See more at: http://www.rheumatology.org/About-Us/Newsroom/Press-Releases/ID/798/ACR-...

The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Rising Physician Exclusion from Medicare and Medicaid

JAMA Network Open has published that an increasing number of physicians are being excluded from Medicare and other forms of public insurance. 

Overall the authors found that the number of physicians excluded from Medicare, Medicaid, and other state public insurance programs increased on average by 20% per year between 2007 and 2017.

No End in Sight for the Shingrix Vaccine Shortage

There is a national shortage of a new shingles vaccine, Shingrix, which is a problem for those who want to start the vaccine and those seeking to receive their second and final injection. 

Since its FDA approval nearly a year ago, sales of the new vaccine have outperformed projections and are expected to approach $1 billion in revenue for 2018. 

Patients Don't Always Tell the Truth

Sometimes patients withhold information from their doctors, and a new study suggests that as much as 60 - 80% of patients consciously omit information to their doctors, despite knowing this may bear on their health and well-being.

Deprescribing to Battle Polypharmacy

The Gerontological Society of America has published a report calling for deprescribing as a means of managing polypharmacy in the elderly.

Limited Impact of Vitamin D Supplementation

A systematic review of 81 studies on vitamin D concludes that vitamin D supplementation does not prevent fractures or falls, or have clinically meaningful effects on bone mineral density.

Metanalyses specifically looked at studies addressing total or hip fractures, falls, or bone mineral density measured at the lumbar spine, total hip, femoral neck, total body, or forearm.